This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of potential therapeutic agents targeting neurological conditions such as depression, anxiety, or neurodegenerative diseases. Its unique structure allows it to interact with specific receptors or enzymes in the brain, making it valuable for exploring new treatment pathways. Additionally, it is used in preclinical studies to evaluate its efficacy, safety, and pharmacokinetic properties, contributing to the discovery of novel drugs for CNS-related ailments.